var data={"title":"Postural tachycardia syndrome","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"topicTitle\">Postural tachycardia syndrome</div><dl id=\"topicContributors\"><dt><span> </span>Authors:</dt><dd><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/contributors\" class=\"contributor contributor_credentials\">Horacio Kaufmann, MD</a></dd><dd><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/contributors\" class=\"contributor contributor_credentials\">Roy Freeman, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/contributors\" class=\"contributor contributor_credentials\">Michael J Aminoff, MD, DSc</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/contributors\" class=\"contributor contributor_credentials\">Janet L Wilterdink, MD</a></dd></dl><p class=\"disclosureLink\"><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/contributor-disclosure\" class=\"contributor contributor_credentials\">Contributor Disclosures</a></p><div id=\"reviewProcess\"><span>All topics are updated as new evidence becomes available and our <a href=\"https://www.uptodate.com/home/editorial-policy\" target=\"_blank\" class=\"policy policy_editorialpolicy\">peer review process</a> is complete.</span></div><div id=\"literatureReviewDate\"><span class=\"emphasis\">Literature review current through:</span>&#160;Feb 2018.&#160;&#124;&#160;<span class=\"emphasis\">This topic last updated:</span>&#160;Mar 03, 2015.</div><div id=\"topicWhatsNewContainer\"></div><div id=\"topicText\"><p class=\"headingAnchor\" id=\"H1\"><span class=\"h1\">INTRODUCTION AND TERMINOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Symptomatic falls in blood pressure after standing or eating are a frequent clinical problem, particularly in the elderly. The symptoms are often due to cerebral hypoperfusion and include generalized weakness, dizziness or lightheadedness, visual blurring or darkening of the visual fields, and, in severe cases, loss of consciousness. These patients often have a decrease in sympathetic activity that leads to systemic hypotension with standing.</p><p>Another form of orthostatic intolerance occurs in patients, particularly younger adults and children, who consistently or frequently experience symptoms of orthostatic intolerance in response to postural stressors. Autonomic reflexes are relatively preserved in these patients, and orthostatic hypotension and syncope rarely occur. Some patients may have slightly elevated blood pressure. The hallmark of this disorder is an exaggerated heart rate increase in response to postural change. This disorder has been called the postural tachycardia syndrome or POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/1-3\" class=\"abstract_t\">1-3</a>].</p><p>The nosology of POTS is confusing; several similar terms have been used to describe the disorder:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Chronic orthostatic intolerance</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mild orthostatic intolerance</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Orthostatic tachycardia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Sympathotonic orthostatic hypotension</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hyperdynamic beta adrenergic state</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Idiopathic hypovolemia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Mitral valve prolapse syndrome</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Neurocirculatory asthenia</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Irritable heart</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Soldier's heart</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Effort syndrome</p><p/><p>This topic will review the clinical features, diagnosis, etiology, and treatment of POTS. Other causes of orthostatic and postprandial hypotension are discussed separately. (See <a href=\"topic.htm?path=mechanisms-causes-and-evaluation-of-orthostatic-hypotension\" class=\"medical medical_review\">&quot;Mechanisms, causes, and evaluation of orthostatic hypotension&quot;</a> and <a href=\"topic.htm?path=treatment-of-orthostatic-and-postprandial-hypotension\" class=\"medical medical_review\">&quot;Treatment of orthostatic and postprandial hypotension&quot;</a>.)</p><p class=\"headingAnchor\" id=\"H2\"><span class=\"h1\">EPIDEMIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The postural tachycardia syndrome (POTS) is the most prevalent form of orthostatic intolerance. It is estimated that 500,000 Americans suffer from this disorder [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/4\" class=\"abstract_t\">4</a>]. It is the most common syndrome of young people seen in autonomic dysfunction clinics [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/5,6\" class=\"abstract_t\">5,6</a>]. Patients present at a relatively young age (14 to 45 years).</p><p>Women predominate among patients with POTS with a female to male ratio of 4-5:1 [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3,7,8\" class=\"abstract_t\">3,7,8</a>]. The reason for this is not known, however, observed gender differences in muscle sympathetic nerve discharge characteristics and decreased stroke volume in healthy patients may explain why women are more likely to develop POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/9,10\" class=\"abstract_t\">9,10</a>].</p><p class=\"headingAnchor\" id=\"H3\"><span class=\"h1\">ETIOLOGY</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The etiology of postural tachycardia syndrome (POTS) is heterogeneous [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/11\" class=\"abstract_t\">11</a>]. Investigators have reported a number of different abnormalities in patients with POTS. It remains uncertain as to which of these abnormalities are primary and causative and which are secondary. Some of the proposed mechanisms discussed below are complementary.</p><p class=\"headingAnchor\" id=\"H4\"><span class=\"h2\">Distal denervation</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Several clinical and empiric observations suggest the presence of distal, predominantly lower extremity, denervation with preserved cardiac innervation in this disorder. These findings include:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Lower extremity anhidrosis [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,12\" class=\"abstract_t\">7,12</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Impaired norepinephrine spillover in the lower extremities [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/13\" class=\"abstract_t\">13</a>], which refers to the measured rate of entry of norepinephrine into the femoral vein in response to various stimuli: sodium <a href=\"topic.htm?path=nitroprusside-drug-information\" class=\"drug drug_general\">nitroprusside</a> infusion, tyramine infusion, the cold pressor test</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased muscle sympathetic nerve activity recruitment in the lower extremity in response to a nitroprusside-induced hypotensive stimulus [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/14\" class=\"abstract_t\">14</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Abnormal quantitative sudomotor axon reflex test, indicating postganglionic sympathetic dysfunction [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7\" class=\"abstract_t\">7</a>]</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased intraepidermal nerve fiber density on skin biopsy [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/15,16\" class=\"abstract_t\">15,16</a>]</p><p/><p>These may result from an underlying autonomic neuropathy that may be postviral or immune-mediated in origin [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/1,17\" class=\"abstract_t\">1,17</a>]. The clinical observation that many cases originate after systemic infection lends some support to this possibility, as does the finding of ganglionic acetylcholine receptor antibody in some patients [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,8,18\" class=\"abstract_t\">7,8,18</a>].</p><p class=\"headingAnchor\" id=\"H5\"><span class=\"h2\">Hypovolemia</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with POTS frequently experience symptomatic improvement with saline infusion. Additional evidence of a decrease <span class=\"nowrap\">and/or</span> redistribution of blood volume is observed in several studies of patients with POTS, which have noted:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Hypovolemia [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,19,20\" class=\"abstract_t\">7,19,20</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Trend toward hypovolemia [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/21\" class=\"abstract_t\">21</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Reduced erythrocyte volume [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3,22\" class=\"abstract_t\">3,22</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Excessive venous pooling with redistributive hypovolemia [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/23\" class=\"abstract_t\">23</a>]</p><p/><p>The underlying cause of the hypovolemia is uncertain. These deficits may be accompanied by impairment of the renin-angiotensin-aldosterone system. In some investigations, despite a relative plasma volume depletion at rest, POTS patients did not have increased plasma renin activity and did have significantly reduced plasma aldosterone compared with controls [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/24-26\" class=\"abstract_t\">24-26</a>]. These observations, combined with the finding of reduced red blood cell volume, has led some investigators to suggest that a renal disorder, perhaps renal denervation, may play a primary role in the etiology of POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3,25,26\" class=\"abstract_t\">3,25,26</a>].</p><p>Alternatively, mild volume constriction may be a secondary phenomenon, the result of chronic sympathetic activation [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3,7\" class=\"abstract_t\">3,7</a>].</p><p class=\"headingAnchor\" id=\"H6\"><span class=\"h2\">Changes in venous function</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Abnormal venous function with decreased venous return on assumption of the upright posture could stimulate a compensatory tachycardia in order to maintain cardiac output.</p><p>There is conflicting evidence on the changes in venous function in POTS. In some case series, military antishock trousers have been shown to attenuate orthostatic tachycardia in the majority of patients [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/23,27\" class=\"abstract_t\">23,27</a>]. There are also reports of decreased stroke volume on assuming upright posture [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/2,28\" class=\"abstract_t\">2,28</a>], excessive venous pooling [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/23,29\" class=\"abstract_t\">23,29</a>], and venous denervation [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/30\" class=\"abstract_t\">30</a>] in patients with POTS. However, empiric measurements of venous compliance have been normal [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/5\" class=\"abstract_t\">5</a>] or decreased [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/21\" class=\"abstract_t\">21</a>]. The latter apparently discordant data may relate to the presence of microvascular transudation in some patients, which may both reduce venous compliance and contribute to venous pooling [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/31\" class=\"abstract_t\">31</a>].</p><p>Abnormal venous function may be the result of sympathetic denervation in the legs, or elevated levels of circulating or locally released vasodilators [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/32\" class=\"abstract_t\">32</a>].</p><p class=\"headingAnchor\" id=\"H189779868\"><span class=\"h2\">Cardiovascular deconditioning</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>A number of studies have associated POTS with cardiovascular deconditioning. In one study of 84 patients with POTS, 90 percent were found to have reduced maximum oxygen uptake, evidence of deconditioning, during exercise [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/33\" class=\"abstract_t\">33</a>]. Another study reported that patients with POTS had smaller left ventricular size compared with controls [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/34\" class=\"abstract_t\">34</a>]. While some suggest that cardiovascular deconditioning play a central role in the pathophysiology of POTS, a causal role has not been proven and it is not clear whether deconditioning is a primary or secondary phenomenon in POTS patients [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/33,35\" class=\"abstract_t\">33,35</a>]. </p><p class=\"headingAnchor\" id=\"H7\"><span class=\"h2\">Baroreflex abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The increase in heart rate without blood pressure change upon standing in POTS suggests a primary abnormality in baroreflex control. There is additional evidence of an attenuated vagal baroreflex response in POTS, as measured by changes in heart rate variability in response to Valsalva maneuver and lower body negative pressure [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/21,36\" class=\"abstract_t\">21,36</a>].</p><p class=\"headingAnchor\" id=\"H8\"><span class=\"h2\">Increased sympathetic activity</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Increased sympathetic activity is the final common pathway of most proposed mechanisms in POTS. Some investigators suggest that increased sympathetic activation (hyperadrenergic state) may be a primary etiologic factor in POTS, as suggested by the following observations in some case series:</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Elevated arterial norepinephrine (NE) levels at rest [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,26,37\" class=\"abstract_t\">7,26,37</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Decreased NE clearance [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/26,38\" class=\"abstract_t\">26,38</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Increased resting heart rate in patients compared with controls [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/6,26,37\" class=\"abstract_t\">6,26,37</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>An exaggerated heart rate response to <a href=\"topic.htm?path=isoproterenol-drug-information\" class=\"drug drug_general\">isoproterenol</a> infusion, suggestive of adrenoreceptor hypersensitivity [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/39\" class=\"abstract_t\">39</a>]</p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>Larger amplitude sympathetic bursts observed in peroneal nerve recordings during rest that, in contrast to controls, does not change during hypotension [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/9\" class=\"abstract_t\">9</a>]</p><p/><p/><p class=\"headingAnchor\" id=\"H9\"><span class=\"h2\">Genetic abnormalities</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>In one large series, 12.5 percent of 152 patients with POTS reported a family history of orthostatic intolerance [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7\" class=\"abstract_t\">7</a>].</p><p>In one family, a mutation was identified in the gene encoding the norepinephrine transporter, which has a pivotal role in norepinephrine uptake at the synaptic cleft [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/40\" class=\"abstract_t\">40</a>]. Impaired norepinephrine clearance may contribute to excessive sympathetic activation, and the observed clinical manifestations of POTS. This finding, while not applicable to most POTS patients, supports a primary etiologic role for excessive sympathetic activation, at least in some patients.</p><p>Polymorphisms in genes encoding nitric oxide synthase [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/41\" class=\"abstract_t\">41</a>] and the beta-2 adrenoreceptor [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/42\" class=\"abstract_t\">42</a>] may also play a role in the genesis of the postural tachycardia syndrome in some patients.</p><p class=\"headingAnchor\" id=\"H10\"><span class=\"h2\">Associated disorders</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The chronic fatigue and the mitral valve prolapse syndromes have clinical features which overlap with this one [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/43,44\" class=\"abstract_t\">43,44</a>]. These disorders are discussed in more detail separately. (See <a href=\"topic.htm?path=mitral-valve-prolapse-syndrome\" class=\"medical medical_review\">&quot;Mitral valve prolapse syndrome&quot;</a> and <a href=\"topic.htm?path=clinical-features-and-diagnosis-of-chronic-fatigue-syndrome-systemic-exertion-intolerance-disease\" class=\"medical medical_review\">&quot;Clinical features and diagnosis of chronic fatigue syndrome (systemic exertion intolerance disease)&quot;</a>.)</p><p>Mast cell activation abnormalities (eg, episodes of flushing associated with abnormal increases in urine methylhistamine) have also been noted in some patients with POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/44\" class=\"abstract_t\">44</a>]. Vasoactive compounds such as histamine are released in mast cell activation and may contribute to clinical manifestations. (See <a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations#H12\" class=\"medical medical_review\">&quot;Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations&quot;, section on 'Clinical manifestations'</a>.) Alternatively, evidence of mast cell activation in POTS may be a secondary (stress-induced) phenomenon.</p><p>POTS has also been associated with Ehlers-Danlos syndrome and joint hypermobility disorders [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/45-47\" class=\"abstract_t\">45-47</a>].</p><p class=\"headingAnchor\" id=\"H11\"><span class=\"h1\">CLINICAL FEATURES</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Patients with postural tachycardia syndrome (POTS) report dizziness, lightheadedness, weakness, blurred vision, and fatigue upon standing [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,18,48\" class=\"abstract_t\">7,18,48</a>]. Other predominantly orthostatic symptoms include palpitations, tremulousness, and anxiety. Gastrointestinal symptoms such as nausea, abdominal cramps, early satiety, bloating, constipation, and diarrhea may be particularly problematic in some [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/11,49\" class=\"abstract_t\">11,49</a>]. There may also be evidence of venous pooling, as manifested by acrocyanosis and edema when upright [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3\" class=\"abstract_t\">3</a>]. Syncope is relatively unusual, but does occur in about 40 percent of patients [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/50\" class=\"abstract_t\">50</a>]. Many patients with POTS report chronic headaches, which are sometimes exacerbated by postural change [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/11\" class=\"abstract_t\">11</a>].</p><p>The symptoms may appear abruptly, often after a viral illness; others experience a more insidious onset [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,8,18\" class=\"abstract_t\">7,8,18</a>]. The severity of symptoms is also quite variable. Some patients experience only mild symptoms and often only in the setting of additional orthostatic stress (eg, menstrual cycle, relative dehydration). Others are profoundly incapacitated. The course of the disorder may be self limited or may follow a relapsing remitting course over several years.</p><p>The pathogenesis of the symptoms in POTS is largely unelucidated [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/11\" class=\"abstract_t\">11</a>]. Interventions that successfully attenuate the tachycardia do not always bring symptomatic relief [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/27\" class=\"abstract_t\">27</a>]. Some of the symptoms suggest cerebral hypoperfusion despite normal systemic blood pressure. However, there is no definitive evidence of abnormal cerebral blood flow or deficient cerebral autoregulation in patients with POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/27,51\" class=\"abstract_t\">27,51</a>].</p><p class=\"headingAnchor\" id=\"H12\"><span class=\"h1\">DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The characteristic autonomic abnormality in patients with postural tachycardia syndrome (POTS) is an exaggerated increase in heart rate on tilt table testing or standing. </p><p>Diagnostic criteria from several laboratories have in common a sustained heart rate increase of greater than 30 beats per minute or an increase to 120 beats per minute or greater within the first 10 minutes of tilt [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/1-3,13,18,29,36,52-54\" class=\"abstract_t\">1-3,13,18,29,36,52-54</a>]. There is usually no orthostatic hypotension (<a href=\"image.htm?imageKey=NEURO%2F56293\" class=\"graphic graphic_figure graphicRef56293 \">figure 1</a>) [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/55\" class=\"abstract_t\">55</a>]. </p><p>Different criteria might be more appropriate in children and adolescents. In one series of children 8 to 19 years old, many normal control children were found to have the changes described above in adults [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/56\" class=\"abstract_t\">56</a>]. In this series, criteria that discriminated between patients and controls were: for children &lt;14 years, a sustained heart rate increase of greater than 40 beats per minute or an increase to 130 beats per minute or greater within the first five minutes of tilt, and for children 14 to 19 years, a sustained heart rate increase of greater than 40 beats per minute or an increase to 120 beats per minute or greater within the first five minutes of tilt. </p><p>These abnormalities may be accompanied by an increase in venous plasma norepinephrine levels at rest and especially upon standing (&gt;600 <span class=\"nowrap\">ng/mL)</span> [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/1,6,8,13,48\" class=\"abstract_t\">1,6,8,13,48</a>]. However, it is not clear what the sensitivity or specificity of this abnormality is for POTS. In one case series of 58 patients whom met clinical criteria for POTS, just 20 percent had abnormal levels [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/8\" class=\"abstract_t\">8</a>].Similarly, some patients with POTS have low 24-hour sodium excretion (&lt;100 mEq) [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/8\" class=\"abstract_t\">8</a>]. Such patients may benefit from salt supplementation. (See <a href=\"#H14\" class=\"local\">'Treatment'</a> below.)</p><p class=\"headingAnchor\" id=\"H13\"><span class=\"h1\">DIFFERENTIAL DIAGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Autonomic neuropathies, central dysautonomias, bedrest deconditioning, side effects of medications, and dehydration can produce similar symptoms to POTS. Ruling out these conditions is essential to making a diagnosis of POTS. (See <a href=\"topic.htm?path=mechanisms-causes-and-evaluation-of-orthostatic-hypotension\" class=\"medical medical_review\">&quot;Mechanisms, causes, and evaluation of orthostatic hypotension&quot;</a>.) </p><p>In most cases, historical information and a neurologic examination specifically looking for other evidence of autonomic failure, neuropathy, and extrapyramidal signs, will provide evidence of the underlying disorder.</p><p>Patients with POTS may be thought to have panic, anxiety, somatization disorder, or chronic fatigue syndrome in part because of the vague nature of the symptoms. In fact, patients with POTS report subjective cognitive dysfunction and have objectively increased scores on inattention scales, and may have an increased prevalence of depression or anxiety [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/15,57\" class=\"abstract_t\">15,57</a>]. The prominent postural nature of the symptoms should prompt the clinician to look for the diagnostic heart rate response.</p><p>The syndrome of inappropriate sinus tachycardia is characterized by an elevated heart rate that is not influenced by postural changes. This disorder is discussed separately. (See <a href=\"topic.htm?path=sinus-tachycardia-evaluation-and-management#H253189891\" class=\"medical medical_review\">&quot;Sinus tachycardia: Evaluation and management&quot;, section on 'Inappropriate sinus tachycardia'</a>.)</p><p class=\"headingAnchor\" id=\"H14\"><span class=\"h1\">TREATMENT</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>The optimal therapy of postural tachycardia syndrome (POTS) is uncertain. No intervention has been systematically studied. The placebo effect may be substantial in POTS, highlighting the need for controlled studies [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/58\" class=\"abstract_t\">58</a>]. </p><p class=\"headingAnchor\" id=\"H22989058\"><span class=\"h2\">Nonpharmacologic measures</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Exacerbating factors, medications, dehydration, and inactivity should be avoided. </p><p>Some clinicians advocate that exercise training should have a central role in treatment of POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/34,35,59\" class=\"abstract_t\">34,35,59</a>]. In one study of 31 patients with orthostatic intolerance, patients in the group randomized to a jogging program were less likely to have residual symptoms after three months compared with controls (37 versus 91 percent) [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/60\" class=\"abstract_t\">60</a>]. Observational studies have reported that a three month exercise training in 19 patients with POTS was associated with attenuated plasma renin and aldosterone increases during standing, improved quality of life, and improved physical fitness and cardiovascular response to exercise [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/61,62\" class=\"abstract_t\">61,62</a>]. </p><p>Because many patients with POTS have a low plasma volume, correction with oral volume expansion, a high salt diet, and <a href=\"topic.htm?path=fludrocortisone-drug-information\" class=\"drug drug_general\">fludrocortisone</a>, a mineralocorticoid receptor agonist may improve symptoms [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/48,63\" class=\"abstract_t\">48,63</a>]. This regimen is similar to that used in orthostatic hypotension. In one case series, measured 24-hour urinary sodium excretion (targeting &gt; 124 <span class=\"nowrap\">mmol/24</span> hours) appeared to be an effective means of monitoring response to salt supplementation [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/64\" class=\"abstract_t\">64</a>]. (See <a href=\"topic.htm?path=treatment-of-orthostatic-and-postprandial-hypotension#H7\" class=\"medical medical_review\">&quot;Treatment of orthostatic and postprandial hypotension&quot;, section on 'Increased salt and water intake'</a> and <a href=\"topic.htm?path=treatment-of-orthostatic-and-postprandial-hypotension#H9\" class=\"medical medical_review\">&quot;Treatment of orthostatic and postprandial hypotension&quot;, section on 'Fludrocortisone'</a>.)</p><p>Some patients report symptomatic benefit with acute ingestion of 16 oz of water and from a saline infusion of 500 to 2000 cc, corresponding to objective improvement in tilt testing response [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3,20,65\" class=\"abstract_t\">3,20,65</a>]. However, it is not clear that this translates to a similar therapeutic response with chronic treatment. </p><p class=\"headingAnchor\" id=\"H22989064\"><span class=\"h2\">Medications</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>There have not been long term, high quality trials testing the efficacy of any pharmacologic approach in POTS. All suggested medications are off label [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/48\" class=\"abstract_t\">48</a>].</p><p><a href=\"topic.htm?path=fludrocortisone-drug-information\" class=\"drug drug_general\">Fludrocortisone</a> (eg, 0.05 to 0.2 mg per day) is most effective when combined with increased salt and water intake. Treatment may be complicated by supine hypertension, fluid retention, and hypokalemia and should be monitored closely. Because of these adverse events and the unknown consequences of chronic mineralocorticoid receptor agonism, lower doses are preferable. &#160;</p><p>Adrenoreceptor agonists may be helpful in some patients (eg, <a href=\"topic.htm?path=midodrine-drug-information\" class=\"drug drug_general\">midodrine</a> 2.5 to 10 mg three times daily). Both intravenous <a href=\"topic.htm?path=phenylephrine-drug-information\" class=\"drug drug_general\">phenylephrine</a> and oral midodrine have been associated with improved symptoms and heart rate response in some patients during tilt testing [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/6,20,66\" class=\"abstract_t\">6,20,66</a>]. However, benefit from chronic therapy is not established.</p><p>Preliminary evidence suggests that the acetylcholinesterase inhibitor <a href=\"topic.htm?path=pyridostigmine-drug-information\" class=\"drug drug_general\">pyridostigmine</a> (30 mg daily) may attenuate the tachycardia and improve symptoms [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/58\" class=\"abstract_t\">58</a>]. Further confirmation from larger trials is needed to establish the benefit of acetylcholinesterase inhibition for POTS.</p><p>Some patients, particularly those troubled by prominent adrenergic symptoms, may benefit from beta blocking agents [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/48\" class=\"abstract_t\">48</a>]. These should be started in low doses and increased gradually (eg, <a href=\"topic.htm?path=propranolol-drug-information\" class=\"drug drug_general\">propranolol</a> 20 to 30 mg three or four times daily). In one placebo-controlled, randomized crossover study, a single low-dose of oral propranolol (20 mg) was associated with improved tachycardia and reduced symptoms, while higher dose propranolol (80 mg) was associated with unchanged or worsened symptoms [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/67\" class=\"abstract_t\">67</a>]. In another placebo-controlled investigation in 11 patients with POTS, treatment with propranolol 20 mg one hour prior to exercise on a semirecumbent bicycle was associated with improved peak oxygen consumption, a measure of exercise capacity [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/68\" class=\"abstract_t\">68</a>]. As with other agents, positive effects on symptoms and tilt testing response in the short term have been reported with propranolol, but long term benefit remains uncertain [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/39,66\" class=\"abstract_t\">39,66</a>].</p><p><a href=\"topic.htm?path=clonidine-drug-information\" class=\"drug drug_general\">Clonidine</a>, <a href=\"topic.htm?path=methyldopa-drug-information\" class=\"drug drug_general\">methyldopa</a>, <a href=\"topic.htm?path=phenobarbital-drug-information\" class=\"drug drug_general\">phenobarbital</a>, erythropoietin, and selective serotonin reuptake inhibitors (SSRIs) are used rarely in POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7,20,69\" class=\"abstract_t\">7,20,69</a>]. Sinus node ablation is not effective; although the sinus rate is effectively slowed, there is no significant improvement in clinical symptoms [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/54\" class=\"abstract_t\">54</a>]. (See <a href=\"topic.htm?path=sinus-tachycardia-evaluation-and-management#H10\" class=\"medical medical_review\">&quot;Sinus tachycardia: Evaluation and management&quot;, section on 'Inappropriate sinus tachycardia'</a>.)</p><p class=\"headingAnchor\" id=\"H810896100\"><span class=\"h1\">PROGNOSIS</span><span class=\"headingEndMark\">&#160;&#8212;&#160;</span>Most patients with POTS have a favorable prognosis. In one case series of 58 patients, most had improved symptoms at one-year followup and more than one-third no longer met diagnostic criteria for POTS [<a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/8\" class=\"abstract_t\">8</a>].</p><p class=\"headingAnchor\" id=\"H15\"><span class=\"h1\">SUMMARY AND RECOMMENDATIONS</span></p><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The postural tachycardia syndrome (POTS) is defined as a form of orthostatic intolerance characterized by an excessive increase in heart rate that occurs on standing without arterial hypotension (see <a href=\"#H1\" class=\"local\">'Introduction and terminology'</a> above).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The etiology of POTS is not clear, but the disorder may be heterogeneous. Abnormalities in autonomic regulation that may either be genetic or acquired are described. Proposed mechanisms include partial sympathetic denervation leading to discordant cardiac and vascular sympathetic control, hypovolemia and impairment of the renin-angiotensin-aldosterone system, venous abnormalities and baroreflex dysfunction (see <a href=\"#H3\" class=\"local\">'Etiology'</a> above).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The clinical symptoms of POTS are varied and nonspecific, and include dizziness, lightheadedness, weakness, blurred vision, and fatigue upon standing. The orthostatic nature of the symptoms is the primary clue to the diagnosis. (See <a href=\"#H11\" class=\"local\">'Clinical features'</a> above.)</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The diagnosis of POTS is established from the history and head-up tilt testing which demonstrates a heart rate increase of &gt;30 bpm over baseline or to &gt;120 bpm. Dehydration, prolonged bedrest, medications, and other dysautonomias should be excluded as etiologies (see <a href=\"#H12\" class=\"local\">'Diagnosis'</a> above and <a href=\"#H13\" class=\"local\">'Differential diagnosis'</a> above).</p><p/><p class=\"bulletIndent1\"><span class=\"glyph\">&#9679;</span>The optimal therapy of POTS is not established. Patients should avoid precipitating factors, and physical activity should be encouraged. We suggest volume repletion and <a href=\"topic.htm?path=fludrocortisone-drug-information\" class=\"drug drug_general\">fludrocortisone</a> (0.05 to 0.2 mg per day) as the first line of therapy (<a href=\"grade.htm?i=6\" class=\"grade\">Grade 2C</a>). Some patients may benefit from <a href=\"topic.htm?path=midodrine-drug-information\" class=\"drug drug_general\">midodrine</a> or beta blocking agents. Other therapies remain under investigation, and further confirmation of benefit is needed before they can be recommended (see <a href=\"#H14\" class=\"local\">'Treatment'</a> above).</p><p/></div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\"><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/1\" class=\"nounderline abstract_t\">Schondorf R, Low PA. Idiopathic postural orthostatic tachycardia syndrome: an attenuated form of acute pandysautonomia? Neurology 1993; 43:132.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/2\" class=\"nounderline abstract_t\">Low PA, Opfer-Gehrking TL, Textor SC, et al. Comparison of the postural tachycardia syndrome (POTS) with orthostatic hypotension due to autonomic failure. J Auton Nerv Syst 1994; 50:181.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/3\" class=\"nounderline abstract_t\">Jacob G, Biaggioni I. Idiopathic orthostatic intolerance and postural tachycardia syndromes. Am J Med Sci 1999; 317:88.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/4\" class=\"nounderline abstract_t\">Robertson D. The epidemic of orthostatic tachycardia and orthostatic intolerance. Am J Med Sci 1999; 317:75.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/5\" class=\"nounderline abstract_t\">Stewart JM. Pooling in chronic orthostatic intolerance: arterial vasoconstrictive but not venous compliance defects. Circulation 2002; 105:2274.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/6\" class=\"nounderline abstract_t\">Furlan R, Jacob G, Snell M, et al. Chronic orthostatic intolerance: a disorder with discordant cardiac and vascular sympathetic control. Circulation 1998; 98:2154.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/7\" class=\"nounderline abstract_t\">Thieben MJ, Sandroni P, Sletten DM, et al. Postural orthostatic tachycardia syndrome: the Mayo clinic experience. Mayo Clin Proc 2007; 82:308.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/8\" class=\"nounderline abstract_t\">Kimpinski K, Figueroa JJ, Singer W, et al. A prospective, 1-year follow-up study of postural tachycardia syndrome. Mayo Clin Proc 2012; 87:746.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/9\" class=\"nounderline abstract_t\">Bonyhay I, Freeman R. Sympathetic neural activity, sex dimorphism, and postural tachycardia syndrome. Ann Neurol 2007; 61:332.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/10\" class=\"nounderline abstract_t\">Fu Q, Arbab-Zadeh A, Perhonen MA, et al. Hemodynamics of orthostatic intolerance: implications for gender differences. Am J Physiol Heart Circ Physiol 2004; 286:H449.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/11\" class=\"nounderline abstract_t\">Benarroch EE. Postural tachycardia syndrome: a heterogeneous and multifactorial disorder. Mayo Clin Proc 2012; 87:1214.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/12\" class=\"nounderline abstract_t\">Khurana RK. Orthostatic intolerance and orthostatic tachycardia: a heterogeneous disorder. Clin Auton Res 1995; 5:12.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/13\" class=\"nounderline abstract_t\">Jacob G, Costa F, Shannon JR, et al. The neuropathic postural tachycardia syndrome. N Engl J Med 2000; 343:1008.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/14\" class=\"nounderline abstract_t\">Bonyhay I, Freeman R. Sympathetic nerve activity in response to hypotensive stress in the postural tachycardia syndrome. Circulation 2004; 110:3193.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/15\" class=\"nounderline abstract_t\">Gibbons CH, Bonyhay I, Benson A, et al. Structural and functional small fiber abnormalities in the neuropathic postural tachycardia syndrome. PLoS One 2013; 8:e84716.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/16\" class=\"nounderline abstract_t\">Haensch CA, Tosch M, Katona I, et al. Small-fiber neuropathy with cardiac denervation in postural tachycardia syndrome. Muscle Nerve 2014; 50:956.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/17\" class=\"nounderline abstract_t\">Vernino S, Low PA, Fealey RD, et al. Autoantibodies to ganglionic acetylcholine receptors in autoimmune autonomic neuropathies. N Engl J Med 2000; 343:847.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/18\" class=\"nounderline abstract_t\">Sandroni P, Opfer-Gehrking TL, McPhee BR, Low PA. Postural tachycardia syndrome: clinical features and follow-up study. Mayo Clin Proc 1999; 74:1106.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/19\" class=\"nounderline abstract_t\">Fouad FM, Tadena-Thome L, Bravo EL, Tarazi RC. Idiopathic hypovolemia. Ann Intern Med 1986; 104:298.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/20\" class=\"nounderline abstract_t\">Jacob G, Shannon JR, Black B, et al. Effects of volume loading and pressor agents in idiopathic orthostatic tachycardia. Circulation 1997; 96:575.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/21\" class=\"nounderline abstract_t\">Farquhar WB, Taylor JA, Darling SE, et al. Abnormal baroreflex responses in patients with idiopathic orthostatic intolerance. Circulation 2000; 102:3086.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/22\" class=\"nounderline abstract_t\">Streeten DH, Thomas D, Bell DS. The roles of orthostatic hypotension, orthostatic tachycardia, and subnormal erythrocyte volume in the pathogenesis of the chronic fatigue syndrome. Am J Med Sci 2000; 320:1.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/23\" class=\"nounderline abstract_t\">Streeten DH, Anderson GH Jr, Richardson R, Thomas FD. Abnormal orthostatic changes in blood pressure and heart rate in subjects with intact sympathetic nervous function: evidence for excessive venous pooling. J Lab Clin Med 1988; 111:326.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/24\" class=\"nounderline abstract_t\">Jacob G, Robertson D, Mosqueda-Garcia R, et al. Hypovolemia in syncope and orthostatic intolerance role of the renin-angiotensin system. Am J Med 1997; 103:128.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/25\" class=\"nounderline abstract_t\">Raj SR, Biaggioni I, Yamhure PC, et al. Renin-aldosterone paradox and perturbed blood volume regulation underlying postural tachycardia syndrome. Circulation 2005; 111:1574.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/26\" class=\"nounderline abstract_t\">Garland EM, Raj SR, Black BK, et al. The hemodynamic and neurohumoral phenotype of postural tachycardia syndrome. Neurology 2007; 69:790.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/27\" class=\"nounderline abstract_t\">Schondorf R, Benoit J, Stein R. Cerebral autoregulation is preserved in postural tachycardia syndrome. J Appl Physiol (1985) 2005; 99:828.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/28\" class=\"nounderline abstract_t\">Gaffney FA, Karlsson ES, Campbell W, et al. Autonomic dysfunction in women with mitral valve prolapse syndrome. Circulation 1979; 59:894.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/29\" class=\"nounderline abstract_t\">Stewart JM, Weldon A. Reflex vascular defects in the orthostatic tachycardia syndrome of adolescents. J Appl Physiol (1985) 2001; 90:2025.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/30\" class=\"nounderline abstract_t\">Streeten DH. Pathogenesis of hyperadrenergic orthostatic hypotension. Evidence of disordered venous innervation exclusively in the lower limbs. J Clin Invest 1990; 86:1582.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/31\" class=\"nounderline abstract_t\">Stewart JM. Microvascular filtration is increased in postural tachycardia syndrome. Circulation 2003; 107:2816.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/32\" class=\"nounderline abstract_t\">Stewart JM, Medow MS, Montgomery LD. Local vascular responses affecting blood flow in postural tachycardia syndrome. Am J Physiol Heart Circ Physiol 2003; 285:H2749.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/33\" class=\"nounderline abstract_t\">Parsaik A, Allison TG, Singer W, et al. Deconditioning in patients with orthostatic intolerance. Neurology 2012; 79:1435.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/34\" class=\"nounderline abstract_t\">Fu Q, Vangundy TB, Galbreath MM, et al. Cardiac origins of the postural orthostatic tachycardia syndrome. J Am Coll Cardiol 2010; 55:2858.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/35\" class=\"nounderline abstract_t\">Joyner MJ, Masuki S. POTS versus deconditioning: the same or different? Clin Auton Res 2008; 18:300.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/36\" class=\"nounderline abstract_t\">Stewart JM. Autonomic nervous system dysfunction in adolescents with postural orthostatic tachycardia syndrome and chronic fatigue syndrome is characterized by attenuated vagal baroreflex and potentiated sympathetic vasomotion. Pediatr Res 2000; 48:218.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/37\" class=\"nounderline abstract_t\">Goldstein DS, Eldadah B, Holmes C, et al. Neurocirculatory abnormalities in chronic orthostatic intolerance. Circulation 2005; 111:839.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/38\" class=\"nounderline abstract_t\">Jacob G, Shannon JR, Costa F, et al. Abnormal norepinephrine clearance and adrenergic receptor sensitivity in idiopathic orthostatic intolerance. Circulation 1999; 99:1706.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/39\" class=\"nounderline abstract_t\">Abe H, Nagatomo T, Kohshi K, et al. Heart rate and plasma cyclic AMP responses to isoproterenol infusion and effect of beta-adrenergic blockade in patients with postural orthostatic tachycardia syndrome. J Cardiovasc Pharmacol 2000; 36 Suppl 2:S79.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/40\" class=\"nounderline abstract_t\">Shannon JR, Flattem NL, Jordan J, et al. Orthostatic intolerance and tachycardia associated with norepinephrine-transporter deficiency. N Engl J Med 2000; 342:541.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/41\" class=\"nounderline abstract_t\">Garland EM, Winker R, Williams SM, et al. Endothelial NO synthase polymorphisms and postural tachycardia syndrome. Hypertension 2005; 46:1103.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/42\" class=\"nounderline abstract_t\">Nickander KK, Carlson PJ, Urrutia RA, et al. A screen of candidate genes and influence of beta2-adrenergic receptor genotypes in postural tachycardia syndrome. Auton Neurosci 2005; 120:97.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/43\" class=\"nounderline abstract_t\">Freeman R, Komaroff AL. Does the chronic fatigue syndrome involve the autonomic nervous system? Am J Med 1997; 102:357.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/44\" class=\"nounderline abstract_t\">Shibao C, Arzubiaga C, Roberts LJ 2nd, et al. Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 2005; 45:385.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/45\" class=\"nounderline abstract_t\">Barron DF, Cohen BA, Geraghty MT, et al. Joint hypermobility is more common in children with chronic fatigue syndrome than in healthy controls. J Pediatr 2002; 141:421.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/46\" class=\"nounderline abstract_t\">Rowe PC, Barron DF, Calkins H, et al. Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 1999; 135:494.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/47\" class=\"nounderline abstract_t\">Gazit Y, Nahir AM, Grahame R, Jacob G. Dysautonomia in the joint hypermobility syndrome. Am J Med 2003; 115:33.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/48\" class=\"nounderline abstract_t\">Raj SR. Postural tachycardia syndrome (POTS). Circulation 2013; 127:2336.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/49\" class=\"nounderline abstract_t\">Ojha A, Chelimsky TC, Chelimsky G. Comorbidities in pediatric patients with postural orthostatic tachycardia syndrome. J Pediatr 2011; 158:20.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/50\" class=\"nounderline abstract_t\">Ojha A, McNeeley K, Heller E, et al. Orthostatic syndromes differ in syncope frequency. Am J Med 2010; 123:245.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/51\" class=\"nounderline abstract_t\">Low PA, Novak V, Spies JM, et al. Cerebrovascular regulation in the postural orthostatic tachycardia syndrome (POTS). Am J Med Sci 1999; 317:124.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/52\" class=\"nounderline abstract_t\">Sandroni P, Opfer-Gehrking TL, Benarroch EE, et al. Certain cardiovascular indices predict syncope in the postural tachycardia syndrome. Clin Auton Res 1996; 6:225.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/53\" class=\"nounderline abstract_t\">Schondorf R, Benoit J, Stein R. Cerebral autoregulation in orthostatic intolerance. Ann N Y Acad Sci 2001; 940:514.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/54\" class=\"nounderline abstract_t\">Low PA, Opfer-Gehrking TL, Textor SC, et al. Postural tachycardia syndrome (POTS). Neurology 1995; 45:S19.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/55\" class=\"nounderline abstract_t\">Freeman R, Wieling W, Axelrod FB, et al. Consensus statement on the definition of orthostatic hypotension, neurally mediated syncope and the postural tachycardia syndrome. Auton Neurosci 2011; 161:46.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/56\" class=\"nounderline abstract_t\">Singer W, Sletten DM, Opfer-Gehrking TL, et al. Postural tachycardia in children and adolescents: what is abnormal? J Pediatr 2012; 160:222.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/57\" class=\"nounderline abstract_t\">Raj V, Haman KL, Raj SR, et al. Psychiatric profile and attention deficits in postural tachycardia syndrome. J Neurol Neurosurg Psychiatry 2009; 80:339.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/58\" class=\"nounderline abstract_t\">Raj SR, Black BK, Biaggioni I, et al. Acetylcholinesterase inhibition improves tachycardia in postural tachycardia syndrome. Circulation 2005; 111:2734.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/59\" class=\"nounderline abstract_t\">Stewart JM. Common syndromes of orthostatic intolerance. Pediatrics 2013; 131:968.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/60\" class=\"nounderline abstract_t\">Winker R, Barth A, Bidmon D, et al. Endurance exercise training in orthostatic intolerance: a randomized, controlled trial. Hypertension 2005; 45:391.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/61\" class=\"nounderline abstract_t\">Fu Q, Vangundy TB, Shibata S, et al. Exercise training versus propranolol in the treatment of the postural orthostatic tachycardia syndrome. Hypertension 2011; 58:167.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/62\" class=\"nounderline abstract_t\">Shibata S, Fu Q, Bivens TB, et al. Short-term exercise training improves the cardiovascular response to exercise in the postural orthostatic tachycardia syndrome. J Physiol 2012; 590:3495.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/63\" class=\"nounderline abstract_t\">The definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. J Auton Nerv Syst 1996; 58:123.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/64\" class=\"nounderline abstract_t\">Zhang Q, Liao Y, Tang C, et al. Twenty-four-hour urinary sodium excretion and postural orthostatic tachycardia syndrome. J Pediatr 2012; 161:281.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/65\" class=\"nounderline abstract_t\">Shannon JR, Diedrich A, Biaggioni I, et al. Water drinking as a treatment for orthostatic syndromes. Am J Med 2002; 112:355.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/66\" class=\"nounderline abstract_t\">Gordon VM, Opfer-Gehrking TL, Novak V, Low PA. Hemodynamic and symptomatic effects of acute interventions on tilt in patients with postural tachycardia syndrome. Clin Auton Res 2000; 10:29.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/67\" class=\"nounderline abstract_t\">Raj SR, Black BK, Biaggioni I, et al. Propranolol decreases tachycardia and improves symptoms in the postural tachycardia syndrome: less is more. Circulation 2009; 120:725.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/68\" class=\"nounderline abstract_t\">Arnold AC, Okamoto LE, Diedrich A, et al. Low-dose propranolol and exercise capacity in postural tachycardia syndrome: a randomized study. Neurology 2013; 80:1927.</a></li><li><a href=\"https://www.uptodate.com/contents/postural-tachycardia-syndrome/abstract/69\" class=\"nounderline abstract_t\">Hoeldtke RD, Streeten DH. Treatment of orthostatic hypotension with erythropoietin. N Engl J Med 1993; 329:611.</a></li></ol></div><div id=\"topicVersionRevision\">Topic 5100 Version 11.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul id=\"innerOutline\"><li class=\"sr-button\"><a href=\"#H15\"><span>SUMMARY &amp; RECOMMENDATIONS</span></a></li><li><a href=\"#H1\" id=\"outline-link-H1\">INTRODUCTION AND TERMINOLOGY</a></li><li><a href=\"#H2\" id=\"outline-link-H2\">EPIDEMIOLOGY</a></li><li><a href=\"#H3\" id=\"outline-link-H3\">ETIOLOGY</a><ul><li><a href=\"#H4\" id=\"outline-link-H4\">Distal denervation</a></li><li><a href=\"#H5\" id=\"outline-link-H5\">Hypovolemia</a></li><li><a href=\"#H6\" id=\"outline-link-H6\">Changes in venous function</a></li><li><a href=\"#H189779868\" id=\"outline-link-H189779868\">Cardiovascular deconditioning</a></li><li><a href=\"#H7\" id=\"outline-link-H7\">Baroreflex abnormalities</a></li><li><a href=\"#H8\" id=\"outline-link-H8\">Increased sympathetic activity</a></li><li><a href=\"#H9\" id=\"outline-link-H9\">Genetic abnormalities</a></li><li><a href=\"#H10\" id=\"outline-link-H10\">Associated disorders</a></li></ul></li><li><a href=\"#H11\" id=\"outline-link-H11\">CLINICAL FEATURES</a></li><li><a href=\"#H12\" id=\"outline-link-H12\">DIAGNOSIS</a></li><li><a href=\"#H13\" id=\"outline-link-H13\">DIFFERENTIAL DIAGNOSIS</a></li><li><a href=\"#H14\" id=\"outline-link-H14\">TREATMENT</a><ul><li><a href=\"#H22989058\" id=\"outline-link-H22989058\">Nonpharmacologic measures</a></li><li><a href=\"#H22989064\" id=\"outline-link-H22989064\">Medications</a></li></ul></li><li><a href=\"#H810896100\" id=\"outline-link-H810896100\">PROGNOSIS</a></li><li><a href=\"#H15\" id=\"outline-link-H15\">SUMMARY AND RECOMMENDATIONS</a></li><li><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"NEURO/5100|FIG\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"FIGURES\">FIGURES</a></div><ul><li><a href=\"image.htm?imageKey=NEURO/56293\" class=\"graphic graphic_figure\">- HR and BP response in tilt table test</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li class=\"plainItem\"><a href=\"topic.htm?path=clinical-features-and-diagnosis-of-chronic-fatigue-syndrome-systemic-exertion-intolerance-disease\" class=\"medical medical_review\">Clinical features and diagnosis of chronic fatigue syndrome (systemic exertion intolerance disease)</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mastocytosis-cutaneous-and-systemic-epidemiology-pathogenesis-and-clinical-manifestations\" class=\"medical medical_review\">Mastocytosis (cutaneous and systemic): Epidemiology, pathogenesis, and clinical manifestations</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mechanisms-causes-and-evaluation-of-orthostatic-hypotension\" class=\"medical medical_review\">Mechanisms, causes, and evaluation of orthostatic hypotension</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=mitral-valve-prolapse-syndrome\" class=\"medical medical_review\">Mitral valve prolapse syndrome</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=sinus-tachycardia-evaluation-and-management\" class=\"medical medical_review\">Sinus tachycardia: Evaluation and management</a></li><li class=\"plainItem\"><a href=\"topic.htm?path=treatment-of-orthostatic-and-postprandial-hypotension\" class=\"medical medical_review\">Treatment of orthostatic and postprandial hypotension</a></li></ul></div></div>","javascript":null}